» Articles » PMID: 10603133

Circulating Inflammatory Cytokine Levels in Hemolytic Uremic Syndrome

Overview
Journal Pediatr Nephrol
Specialties Nephrology
Pediatrics
Date 1999 Dec 22
PMID 10603133
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

Experimental data suggest that the host's inflammatory response is involved in the pathophysiology of verotoxin-producing Escherichia coli (VTEC)-associated hemolytic uremic syndrome (HUS). We compared the circulating levels of pro- [interleukin (IL)-6, IL-8] and anti-inflammatory [IL-10 and IL-1 receptor antagonist (Ra)] mediators on enrollment among children with HUS due to E. coli O157:H7, according to the severity of renal dysfunction. The latter was evaluated by the occurrence of oligoanuria, the requirement for dialysis, and a glomerular filtration rate (GFR) </=80 ml/min per 1. 73 m(2) measured 1 year later. Increased levels of IL-6 (P<0.0001), IL-10 (P<0.0001), and IL-1Ra (P<0.07) were found among patients with HUS compared with normal controls. Children with severe renal dysfunction also had tenfold increased levels of IL-6 and higher concentrations of IL-10 and IL-1Ra. Both the IL-6/IL-10 (4.9+/-8.3 vs. 0.5+/-0.4, P=0.01) and the IL-6/IL-1Ra ratios (0.10+/-0.20 vs. 0. 01+/-0.01, P=0.04) were significantly increased. GFR correlated well with IL-6 levels, IL-6/IL-10 and IL-6/IL-1Ra ratios. Our data demonstrate that the inflammatory response of the host is associated with the severity of renal dysfunction during classic HUS. An imbalance between the pro- and the anti-inflammatory responses may be involved in the pathophysiology of VTEC-associated HUS.

Citing Articles

Transition from acute kidney injury to chronic kidney disease in a long-term murine model of Shiga toxin-induced hemolytic-uremic syndrome.

Wegener J, Dennhardt S, Loeffler I, Coldewey S Front Immunol. 2024; 15:1469353.

PMID: 39450175 PMC: 11499141. DOI: 10.3389/fimmu.2024.1469353.


Assessment of interleukin-10 promoter variant (-1082A/G) and cytokine production in patients with hemolytic uremic syndrome.

Mongelos M, Sosa F, Pineda G, Fiorentino G, Santiago A, Abelleyro M Front Pediatr. 2023; 11:1210158.

PMID: 37425258 PMC: 10327435. DOI: 10.3389/fped.2023.1210158.


Is haem the real target of COVID-19?.

Rapozzi V, Juarranz A, Habib A, Ihan A, Strgar R Photodiagnosis Photodyn Ther. 2021; 35:102381.

PMID: 34119708 PMC: 8192263. DOI: 10.1016/j.pdpdt.2021.102381.


Linking COVID-19 and Heme-Driven Pathophysiologies: A Combined Computational-Experimental Approach.

Hopp M, Domingo-Fernandez D, Gadiya Y, Detzel M, Graf R, Schmalohr B Biomolecules. 2021; 11(5).

PMID: 33925394 PMC: 8147026. DOI: 10.3390/biom11050644.


Activation of the Nlrp3 Inflammasome Contributes to Shiga Toxin-Induced Hemolytic Uremic Syndrome in a Mouse Model.

Song L, Xiao Y, Li X, Huang Y, Meng G, Ren Z Front Immunol. 2021; 11:619096.

PMID: 33552083 PMC: 7859089. DOI: 10.3389/fimmu.2020.619096.